Structures by: Hegazy A. S.
Total: 54
2-[3-(4-Chlorophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]-5-[(4-fluorophenyl)diazenyl]-4-methylthiazole
C25H18ClF2N5S
IUCrData (2020) 5, 5 x200700
a=16.9376(6)Å b=13.1440(4)Å c=10.6399(4)Å
α=90° β=92.891(4)° γ=90°
5-[(4-Bromophenyl)diazenyl]-2-{2-[1-(1<i>H</i>-indol-3-yl)ethylidene]hydrazinyl}-4-methylthiazole dimethylformamide hemisolvate
C20H17BrN6S,0.5(C3H7NO)
IUCrData (2018) 3, 10 x181378
a=9.9957(6)Å b=14.5325(9)Å c=15.8353(10)Å
α=81.671(5)° β=81.344(5)° γ=80.469(5)°
5-Methyl-1-(4-methylphenyl)-<i>N</i>'-[1-(thiophen-2-yl)ethylidene]-1<i>H</i>-1,2,3-triazole-4-carbohydrazide
C17H17N5OS
IUCrData (2018) 3, 10
a=9.0292(7)Å b=9.8640(10)Å c=10.8754(9)Å
α=111.021(9)° β=105.103(8)° γ=96.945(7)°
2-[5-(4-Fluorophenyl)-3-(4-methylphenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]-4-(5-methyl-1-phenyl-1<i>H</i>-1,2,3-triazol-4-yl)thiazole
C28H23FN6S
IUCrData (2019) 4, 2 x190240
a=6.4930(7)Å b=13.8065(10)Å c=27.539(2)Å
α=90° β=90° γ=90°
2-[3-(4-Chlorophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]-8<i>H</i>-indeno[1,2-<i>d</i>]thiazole
C25H17ClFN3S
IUCrData (2019) 4, 2 x190218
a=11.6975(6)Å b=11.0671(5)Å c=16.5395(10)Å
α=90° β=100.303(6)° γ=90°
1-(4-Fluorophenyl)-5-methyl-<i>N</i>'-{1-[5-methyl-1-(4-methylphenyl)-1<i>H</i>-1,2,3-triazol-4-yl]ethylidene}-1<i>H</i>-1,2,3-triazole-4-carbohydrazide
C22H21FN8O
IUCrData (2019) 4, 2 x190261
a=12.2574(10)Å b=7.6912(8)Å c=22.821(3)Å
α=90° β=90° γ=90°
3-[5-Methyl-1-(4-methylphenyl)-1<i>H</i>-1,2,3-triazol-4-yl]-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C20H17N5O
IUCrData (2019) 4, 2 x190217
a=9.7894(7)Å b=10.9830(6)Å c=17.2596(8)Å
α=93.490(4)° β=95.702(5)° γ=107.729(6)°
4-(Benzofuran-2-yl)-2-[3-(4-chlorophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]thiazole
C26H17ClFN3OS
IUCrData (2019) 4, 3 x190359
a=6.6631(6)Å b=15.2297(17)Å c=22.431(3)Å
α=90° β=96.390(9)° γ=90°
5-[(4-Chlorophenyl)diazenyl]-2-[5-(4-fluorophenyl)-3-(furan-2-yl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]-4-methylthiazole
C23H17ClFN5OS
IUCrData (2019) 4, 2 x190211
a=5.2879(3)Å b=26.3742(10)Å c=15.7872(7)Å
α=90° β=98.293(4)° γ=90°
3-{2-[3-(4-Chlorophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]thiazol-4-yl}-3,8a-dihydro-2<i>H</i>-chromen-2-one
C27H17ClFN3O2S
IUCrData (2019) 4, 2 x190170
a=7.9243(5)Å b=23.7112(9)Å c=24.9270(15)Å
α=90° β=90° γ=90°
5-[5-(4-Chlorophenyl)isoxazol-3-yl]-<i>N</i>-phenyl-1,3,4-oxadiazol-2-amine
C17H11ClN4O2
IUCrData (2019) 4, 1 x190136
a=17.8925(15)Å b=7.4168(6)Å c=11.5006(9)Å
α=90° β=102.061(8)° γ=90°
(<i>E</i>)-2-Benzoyl-3-[1-phenyl-3-(thiophen-2-yl)-1<i>H</i>-pyrazol-4-yl]acrylonitrile
C23H15N3OS
IUCrData (2018) 3, 1 x180171
a=19.2666(10)Å b=9.7769(4)Å c=20.3265(12)Å
α=90° β=94.423(5)° γ=90°
2-(5-Methyl-1-phenyl-1<i>H</i>-1,2,3-triazol-4-yl)-5-phenyl-1,3,4-oxadiazole
C17H13N5O
IUCrData (2018) 3, 7 x180966
a=23.5234(10)Å b=10.5928(4)Å c=23.4895(13)Å
α=90° β=90° γ=90°
5-Methyl-1-(4-methylphenyl)-<i>N</i>'-[1-(1<i>H</i>-pyrrol-2-yl)ethylidene]-1<i>H</i>-1,2,3-triazole-4-carbohydrazide monohydrate
C17H18N6O,H2O
IUCrData (2018) 3, 8 x181162
a=7.3968(8)Å b=10.6475(9)Å c=12.7769(13)Å
α=106.577(9)° β=100.809(9)° γ=108.208(9)°
Sodium 1-(4-chlorophenyl)-5-methyl-1<i>H</i>-1,2,3-triazole-4-carboxylate
Na,C10H7ClN3O2
IUCrData (2018) 3, 8 x181127
a=11.6462(8)Å b=6.3754(4)Å c=14.7003(9)Å
α=90° β=92.711(7)° γ=90°
Ethyl 2-anilino-4-methyl-5-[5-methyl-1-(4-methylphenyl)-1<i>H</i>-1,2,3-triazole-4-carbonyl]thiophene-3-carboxylate
C25H24N4O3S
IUCrData (2018) 3, 8 x181106
a=8.3287(7)Å b=13.8956(9)Å c=20.3124(15)Å
α=90° β=90.635(8)° γ=90°
5-Methyl-<i>N</i>'-(5-methyl-1-phenyl-1<i>H</i>-1,2,3-triazole-4-carbonyl)-1-phenyl-1<i>H</i>-1,2,3-triazole-4-carbohydrazide
C20H18N8O2
IUCrData (2018) 3, 3 x180424
a=61.5399(18)Å b=11.8988(4)Å c=8.2661(3)Å
α=90° β=93.301(3)° γ=90°
1-{2-Anilino-4-methyl-5-[5-methyl-1-(4-methylphenyl)-1<i>H</i>-1,2,3-triazole-4-carbonyl]thiophen-3-yl}ethanone
C24H22N4O2S
IUCrData (2018) 3, 3 x180402
a=6.2938(5)Å b=10.9254(9)Å c=31.229(4)Å
α=90° β=90.221(8)° γ=90°
(<i>E</i>)-1-[5-Methyl-1-(4-methylphenyl)-1<i>H</i>-1,2,3-triazol-4-yl]-3-(4-nitrophenyl)prop-2-en-1-one
C19H16N4O3
IUCrData (2018) 3, 6 x180841
a=37.0489(16)Å b=13.3154(7)Å c=6.9170(4)Å
α=90° β=93.771(4)° γ=90°
1-[5-Methyl-1-(4-methylphenyl)-1<i>H</i>-1,2,3-triazol-4-yl]ethanone
C12H13N3O
IUCrData (2017) 2, 12 x171782
a=5.7747(4)Å b=6.5171(5)Å c=30.234(2)Å
α=90° β=95.342(7)° γ=90°
Methyl 5-(1-benzofuran-2-yl)isoxazole-3-carboxylate
C13H9NO4
IUCrData (2017) 2, 12 x171820
a=11.5170(6)Å b=8.7431(4)Å c=22.2595(13)Å
α=90° β=90° γ=90°
(<i>E</i>)-1-(4-Bromophenyl)-3-[3-(5-methyl-1-phenyl-1<i>H</i>-1,2,3-triazol-4-yl)-1-phenyl-1<i>H</i>-pyrazol-4-yl]prop-2-en-1-one
C27H20BrN5O
IUCrData (2018) 3, 1 x180069
a=15.0387(12)Å b=6.8105(3)Å c=24.385(2)Å
α=90° β=106.473(8)° γ=90°
2-({6-[5-Methyl-1-(4-methylphenyl)-1<i>H</i>-1,2,3-triazol-4-yl]imidazo[2,1-<i>b</i>]thiazol-5-yl}methylidene)hydrazinecarbothioamide dimethylformamide 0.25-solvate
4(C17H16N8S2),C3H7NO
IUCrData (2018) 3, 1 x180087
a=18.3427(14)Å b=13.5855(10)Å c=16.9385(12)Å
α=90° β=110.393(9)° γ=90°
1,1-Dimethyl-3-[4-(trifluoromethyl)phenyl]urea
C10H11F3N2O
IUCrData (2018) 3, 1 x180040
a=9.8152(3)Å b=10.0783(2)Å c=22.5120(7)Å
α=90° β=90° γ=90°
Methyl <i>N</i>-(2-bromo-4-chlorophenyl)carbamate
C8H7BrClNO2
IUCrData (2018) 3, 1 x180054
a=4.6637(3)Å b=9.4598(6)Å c=11.9898(7)Å
α=111.639(5)° β=101.035(5)° γ=93.712(5)°
(<i>E</i>)-3-(4-Fluorophenyl)-1-[1-(4-fluorophenyl)-5-methyl-1<i>H</i>-1,2,3-triazol-4-yl]prop-2-en-1-one
C18H13F2N3O
IUCrData (2018) 3, 1 x171841
a=8.1891(4)Å b=14.1804(6)Å c=14.5050(6)Å
α=68.075(4)° β=84.220(4)° γ=74.627(4)°
1-(2-Bromo-4-methylphenyl)-3,3-dimethylthiourea
C10H13BrN2S
IUCrData (2018) 3, 1 x180045
a=12.2617(7)Å b=8.0222(4)Å c=12.7397(7)Å
α=90° β=112.380(6)° γ=90°
Ethyl 1-phenyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazole-3-carboxylate
C19H16N2O2
IUCrData (2018) 3, 1 x171840
a=32.387(3)Å b=9.8559(15)Å c=5.0043(8)Å
α=90° β=90° γ=90°
Ethyl (<i>Z</i>)-2-[2-(4-methylphenyl)hydrazin-1-ylidene]-3-oxo-3-(thiazol-2-ylamino)propanoate
C15H16N4O3S
IUCrData (2018) 3, 1 x171852
a=5.6487(3)Å b=16.7479(11)Å c=16.9726(14)Å
α=90° β=90° γ=90°
4-(4-Bromophenyl)-2-(3-(4-chlorophenyl)-5-{3-[5-methyl-1-(4-methylphenyl)-1<i>H</i>-1,2,3-triazol-4-yl]-1-phenyl-1<i>H</i>-pyrazol-4-yl}-4,5-dihydro-1<i>H</i>-pyrazol-1-yl)thiazole
C37H28BrClN8S
IUCrData (2018) 3, 1 x180036
a=10.4220(7)Å b=13.4232(5)Å c=23.8943(14)Å
α=90° β=90.198(6)° γ=90°
4-(4-Bromophenyl)-2-(3-(4-bromophenyl)-5-{3-[5-methyl-1-(4-methylphenyl)-1<i>H</i>-1,2,3-triazol-4-yl]-1-phenyl-1<i>H</i>-pyrazol-4-yl}-4,5-dihydro-1<i>H</i>-pyrazol-1-yl)-1,3-thiazole
C37H28Br2N8S
IUCrData (2018) 3, 3 x180449
a=10.3624(2)Å b=13.5082(3)Å c=24.0262(6)Å
α=90° β=90.457(2)° γ=90°
4-(4-Bromophenyl)-2-(3-(4-chlorophenyl)-5-{3-[5-methyl-1-(4-methylphenyl)-1<i>H</i>-1,2,3-triazol-4-yl]-1-phenyl-1<i>H</i>-pyrazol-4-yl}-4,5-dihydro-1<i>H</i>-pyrazol-1-yl)-1,3-thiazole
C37H28BrClN8S
IUCrData (2018) 3, 3 x180443
a=10.4422(3)Å b=13.3065(3)Å c=24.0683(8)Å
α=90° β=90.181(3)° γ=90°
C9H9NO2
C9H9NO2
Chemical communications (Cambridge, England) (2010) 46, 16 2790-2792
a=7.2640(5)Å b=7.8940(6)Å c=8.3280(8)Å
α=104.845(3)° β=114.462(4)° γ=103.622(5)°
C17H17NO4
C17H17NO4
Chemical communications (Cambridge, England) (2010) 46, 16 2790-2792
a=7.5240(3)Å b=9.4100(3)Å c=11.9960(5)Å
α=83.877(2)° β=77.311(2)° γ=68.559(2)°
C14H11NO2,C4H8O2
C14H11NO2,C4H8O2
Chemical communications (Cambridge, England) (2010) 46, 16 2790-2792
a=7.5698(6)Å b=9.2785(8)Å c=12.2934(10)Å
α=78.473(4)° β=82.365(4)° γ=70.596(3)°
C15H21NO3
C15H21NO3
Chemical communications (Cambridge, England) (2010) 46, 16 2790-2792
a=9.7517(5)Å b=13.5852(7)Å c=11.0154(4)Å
α=90.00° β=95.266(3)° γ=90.00°
4-Methoxyquinazoline
C9H8N2O
Acta Crystallographica Section E (2014) 70, 12 o1279
a=6.9590(6)Å b=4.0517(3)Å c=13.5858(12)Å
α=90° β=91.754(8)° γ=90°
2,2-Dimethyl-<i>N</i>-(pyridin-3-yl)propanamide
C10H14N2O
Acta Crystallographica Section E (2015) 71, 4 o246-o247
a=11.2453(3)Å b=10.5272(3)Å c=17.5339(6)Å
α=90° β=90° γ=90°
2-(1-Methylethyl)-1,3-thiazolo[4,5-<i>b</i>]pyridine
C9H10N2S
Acta Crystallographica Section E (2015) 71, 5 o272-o273
a=9.6376(2)Å b=10.1602(2)Å c=8.9254(2)Å
α=90° β=90° γ=90°
2-(3-Nitrophenyl)-1,3-thiazolo[4,5-<i>b</i>]pyridine
C12H7N3O2S
Acta Crystallographica Section E (2015) 71, 11 o877
a=9.5596(2)Å b=9.8733(2)Å c=11.5606(3)Å
α=90° β=98.122(2)° γ=90°
2-Cyclohexyl-1,3-thiazolo[4,5-<i>b</i>]pyridine
C12H14N2S
Acta Crystallographica Section E (2015) 71, 11 o866
a=7.8884(5)Å b=11.8079(7)Å c=12.2134(6)Å
α=90° β=100.589(6)° γ=90°
3-Amino-2-ethylquinazolin-4(3<i>H</i>)-one
C10H11N3O
Acta Crystallographica Section E (2015) 71, 9 o650-o651
a=7.0230(5)Å b=7.6198(7)Å c=9.7868(6)Å
α=69.709(7)° β=89.242(5)° γ=75.191(7)°
3-Amino-2-propylquinazolin-4(3<i>H</i>)-one
C11H13N3O
Acta Crystallographica Section E (2015) 71, 8 o590-o591
a=24.1525(5)Å b=24.1525(5)Å c=9.6500(2)Å
α=90° β=90° γ=120°
2-(2-Methylphenyl)-1,3-thiazolo[4,5-<i>b</i>]pyridine
C13H10N2S
Acta Crystallographica Section E (2015) 71, 8 o562-o563
a=7.67020(10)Å b=12.6492(3)Å c=22.9821(5)Å
α=90° β=90° γ=90°
2,2-Dimethyl-<i>N</i>-(5-methylpyridin-2-yl)propanamide
C11H16N2O
Acta Crystallographica Section E (2015) 71, 6 o419-o420
a=11.1969(2)Å b=8.6439(2)Å c=23.8844(5)Å
α=90° β=94.549(2)° γ=90°
1-(2-Bromo-4-chlorophenyl)-3,3-dimethylthiourea
C9H10BrClN2S
Acta Crystallographica Section E (2014) 70, 6 o704
a=12.1369(3)Å b=7.9431(2)Å c=13.2230(4)Å
α=90° β=115.386(3)° γ=90°
4-Methylsulfanyl-2-phenylquinazoline
C15H12N2S
Acta Crystallographica Section E (2014) 70, 8 o871
a=10.1951(3)Å b=7.3545(2)Å c=16.5300(5)Å
α=90° β=102.860(3)° γ=90°
2-<i>tert</i>-Butyl-1,3-thiazolo[4,5-<i>b</i>]pyridine
C10H12N2S
Acta Crystallographica Section E (2014) 70, 9 o932
a=9.4606(3)Å b=9.7999(3)Å c=11.1155(4)Å
α=90° β=90° γ=90°
2-Ethylquinazoline-4(3<i>H</i>)-thione
C10H10N2S
Acta Crystallographica Section E (2014) 70, 9 o953
a=5.8231(3)Å b=14.3214(6)Å c=21.7365(8)Å
α=90° β=90° γ=90°
2-Ethyl-3-[(<i>R</i>)-2-phenylbutanamido]quinazolin-4(3<i>H</i>)-one monohydrate
C20H21N3O2,H2O
Acta Crystallographica Section E (2014) 70, 4 o467
a=14.5354(2)Å b=7.35290(10)Å c=18.1945(3)Å
α=90° β=98.5910(10)° γ=90°
2,2-Dimethyl-<i>N</i>-(4-methylpyridin-2-yl)propanamide
C11H16N2O
Acta Crystallographica Section E (2014) 70, 3 o351-o352
a=10.7954(3)Å b=10.1809(2)Å c=20.8390(5)Å
α=90° β=90° γ=90°
4-(2,2-Dimethylpropanamido)pyridin-3-yl <i>N</i>,<i>N</i>-diisopropyldithiocarbamate
C17H27N3OS2
Acta Crystallographica Section E (2014) 70, 9 o1069-o1070
a=7.9776(7)Å b=9.5412(9)Å c=13.0541(14)Å
α=83.099(8)° β=83.227(8)° γ=84.608(7)°
2-[4-(Methylsulfanyl)quinazolin-2-yl]-1-phenylethanol
C17H16N2OS
Acta Crystallographica Section E (2014) 70, 10 o1101
a=15.6142(3)Å b=5.61420(10)Å c=17.2355(3)Å
α=90° β=101.138(2)° γ=90°
4,4-Dibutyl-2-phenyl-3,4-dihydroquinazoline
C22H28N2
Acta Crystallographica Section E (2014) 70, 10 o1100
a=19.2953(8)Å b=9.9889(3)Å c=9.6341(4)Å
α=90° β=96.667(4)° γ=90°